Bass suffers another IPR setback
Antonio Guillem / Shutterstock.com
The Patent Trial and Appeal Board (PTAB) has rejected another inter partes review (IPR) petition filed by hedge fund manager Kyle Bass’s organisation the Coalition for Affordable Drugs.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at email@example.com
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Kyle Bass; USPTO; PTAB; IPR; Coalition for Affordable Drugs; Pharmacyclics; hedge fund